ALS is an incurable nervous system disease that causes the loss of muscle control. A research team at the University of ...

The EXPErimental medicine Route To Success in ALS (EXPERTS-ALS) project aims to rapidly screen potential drugs for evidence ...

After years of stagnation in the treatment of neurodegenerative disorder amyotrophic lateral sclerosis (ALS), patients in the US could soon have two new treatment options – but their pricing is ...

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

A 22-month survival benefit was seen for a subset of ALS patients whose disease did not progress when treated with NP001 in ...

Treatment with IV edaravone for ALS was linked to a slowing of disease-progression milestones compared with no IV edaravone ...

ALS is an incurable nervous system disease that causes the loss of muscle control. A research team at the University of Alberta is looking for volunteers as they work to find possible causes and ...

The Valentine Plunge has raised nearly $5 million for the Joan Dancy and P.A.L.S. (People with ALS) Foundation.

and there is currently no cure to stop the disease. Scientists from KU Leuven and the VIB Center for Brain Research have now made a remarkable discovery: small, antenna-like structures on cells, the ...

An announcement from Neurosense Therapeutics Ltd. ( (NRSN) ) is now available.

Nader Yaghoubi, M.D., Ph.D., PathMaker’s Co-Founder and CEO, stated, “We are pleased to announce IRB approval for the CALM study, which allows us to commence enrollments shortly. Given the mechanisms ...